Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Lower ghrelin levels and certain gene variations may increase acne risk.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Excess androgens may cause PCOS, not just be a symptom.

Androgens may worsen COVID-19 severity in men.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Five molecular elements identified as potential future targets for hair loss therapy.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Antibody treatments show promise for hair loss but need more research.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Phyla nodiflora contains compounds that may help treat diabetes, hair loss, cancer, and fluid retention.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Combining nanotechnology with herbal medicine may improve PCOS treatment.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Using existing drugs for new treatments is cost-effective and safer.

Exosomes may improve hair growth, but more research is needed for safety and approval.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.